NasdaqGS:IMCRBiotechs
A Look At Immunocore Holdings (IMCR) Valuation After Strong First Quarter 2026 Results
Why Immunocore Holdings (IMCR) Is Back On Investor Radar
Immunocore Holdings (IMCR) has drawn fresh attention after reporting first quarter 2026 results, with revenue of US$106.68 million and net income of US$12.97 million compared with US$93.88 million and US$5.02 million a year earlier.
See our latest analysis for Immunocore Holdings.
Despite the stronger first quarter figures and a recent shelf registration for up to 2,497,743 ordinary shares, Immunocore Holdings’ share price has slipped,...